Insider Selling: Alignment Healthcare, Inc. (NASDAQ:ALHC) CFO Sells 4,483 Shares of Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) CFO Robert Thomas Freeman sold 4,483 shares of the business’s stock in a transaction on Tuesday, October 29th. The stock was sold at an average price of $12.01, for a total transaction of $53,840.83. Following the sale, the chief financial officer now owns 159,626 shares in the company, valued at $1,917,108.26. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Robert Thomas Freeman also recently made the following trade(s):

• On Thursday, October 31st, Robert Thomas Freeman sold 36,197 shares of Alignment Healthcare stock. The stock was sold at an average price of $12.04, for a total transaction of $435,811.88.
• On Monday, October 14th, Robert Thomas Freeman sold 30,500 shares of Alignment Healthcare stock. The stock was sold at an average price of $11.50, for a total transaction of $350,750.00.
• On Tuesday, October 8th, Robert Thomas Freeman sold 39,320 shares of Alignment Healthcare stock. The stock was sold at an average price of $12.04, for a total transaction of $473,412.80.
• On Tuesday, October 1st, Robert Thomas Freeman sold 21,375 shares of Alignment Healthcare stock. The stock was sold at an average price of $10.66, for a total transaction of $227,857.50.
• On Friday, September 13th, Robert Thomas Freeman sold 14,500 shares of Alignment Healthcare stock. The stock was sold at an average price of $12.00, for a total transaction of $174,000.00.
• On Wednesday, September 11th, Robert Thomas Freeman sold 8,561 shares of Alignment Healthcare stock. The shares were sold at an average price of $10.01, for a total transaction of $85,695.61.
• On Wednesday, September 4th, Robert Thomas Freeman sold 1,650 shares of Alignment Healthcare stock. The shares were sold at an average price of $10.00, for a total transaction of $16,500.00.

Alignment Healthcare Stock Up 4.4 %

ALHC opened at $12.95 on Friday. The company has a market cap of $2.48 billion, a PE ratio of -16.82 and a beta of 1.47. Alignment Healthcare, Inc. has a 1 year low of $4.46 and a 1 year high of $12.99. The firm has a 50 day moving average price of $10.82 and a 200 day moving average price of $8.79. The company has a debt-to-equity ratio of 1.82, a quick ratio of 1.61 and a current ratio of 1.60.

Alignment Healthcare (NASDAQ:ALHC) last released its quarterly earnings results on Tuesday, October 29th. The company reported ($0.14) earnings per share for the quarter, hitting analysts’ consensus estimates of ($0.14). The firm had revenue of $692.43 million during the quarter, compared to analysts’ expectations of $662.11 million. Alignment Healthcare had a negative return on equity of 108.69% and a negative net margin of 5.84%. Alignment Healthcare’s quarterly revenue was up 51.6% compared to the same quarter last year. During the same quarter in the prior year, the business earned ($0.19) EPS. Sell-side analysts expect that Alignment Healthcare, Inc. will post -0.68 earnings per share for the current year.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on ALHC. Robert W. Baird boosted their target price on shares of Alignment Healthcare from $10.00 to $11.00 and gave the company an “outperform” rating in a research note on Wednesday, August 14th. UBS Group upped their price objective on shares of Alignment Healthcare from $9.00 to $12.00 and gave the company a “neutral” rating in a research note on Wednesday. KeyCorp began coverage on shares of Alignment Healthcare in a research note on Friday, October 11th. They set a “sector weight” rating for the company. Stifel Nicolaus upped their price objective on shares of Alignment Healthcare from $9.00 to $12.00 and gave the company a “buy” rating in a research note on Friday, July 26th. Finally, TD Cowen upped their price objective on shares of Alignment Healthcare from $8.00 to $10.00 and gave the company a “buy” rating in a research note on Tuesday, August 6th. One research analyst has rated the stock with a sell rating, three have given a hold rating, six have given a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, Alignment Healthcare currently has an average rating of “Moderate Buy” and an average price target of $10.33.

Hedge Funds Weigh In On Alignment Healthcare

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Creative Planning boosted its holdings in Alignment Healthcare by 20.0% in the 3rd quarter. Creative Planning now owns 12,442 shares of the company’s stock worth $147,000 after acquiring an additional 2,072 shares during the period. Principal Financial Group Inc. boosted its stake in shares of Alignment Healthcare by 18.1% during the 2nd quarter. Principal Financial Group Inc. now owns 13,521 shares of the company’s stock valued at $106,000 after buying an additional 2,077 shares during the last quarter. Allspring Global Investments Holdings LLC boosted its stake in shares of Alignment Healthcare by 9.2% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 39,570 shares of the company’s stock valued at $196,000 after buying an additional 3,334 shares during the last quarter. nVerses Capital LLC purchased a new position in shares of Alignment Healthcare during the 3rd quarter valued at approximately $95,000. Finally, The Manufacturers Life Insurance Company boosted its stake in shares of Alignment Healthcare by 20.9% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 55,531 shares of the company’s stock valued at $434,000 after buying an additional 9,595 shares during the last quarter. Hedge funds and other institutional investors own 86.19% of the company’s stock.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.